Early pandemic influenza (2009 H1N1) in Ho Chi Minh city, Vietnam: A clinical virological and epidemiological analysis

PLoS Medicine

Volumn 7, Issue 5, 2010, Pages

  Hien, Tran Tinh ^a,b,c   Boni, Maciej F ^a,d,e   Bryant, Juliet E ^a,e   Ngan, Tran Thuy ^a,c   Wolbers, Marcel ^a,e   Nguyen, Tran Dang ^a   Truong, Nguyen Thanh ^b   Dung, Nguyen Thi ^b   Ha, Do Quang ^a   Hien, Vo Minh ^a,b   Thanh, Tran Tan ^a   Nhu, Le Nguyen Truc ^a   Uyen, Le Thi Tam ^a,b   Nhien, Pham Thi ^b   Chinh, Nguyen Tran ^b   Chau, Nguyen van Vinh ^b   Farrar, Jeremy ^a,c,e   van Doorn, H Rogier ^a,c,e  

^a OXFORD UNIVERSITY CLINICAL RESEARCH UNIT   (Viet Nam)

^b UNIVERSITY COLLEGE LONDON HOSPITALS   (United Kingdom)

^c Southeast Asian Infectious Diseases Clinical Research Network   (Indonesia)

^d UNIVERSITY OF OXFORD   (United Kingdom)

^e UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

OSELTAMIVIR;

ADOLESCENT; ADULT; AGED; AIRPORT; ANTIVIRAL THERAPY; ARTICLE; BODY TEMPERATURE; CHILD; DRUG EFFICACY; FEMALE; FLU LIKE SYNDROME; HUMAN; INCIDENCE; INFLUENZA A (H1N1); MAJOR CLINICAL STUDY; MALE; PANDEMIC INFLUENZA; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCREENING TEST; TREATMENT DURATION; VIET NAM; VIRUS CULTURE; VIRUS ISOLATION; VIRUS LOAD; VIRUS RESISTANCE; VIRUS TRANSMISSION; AIRCRAFT; DISEASE TRANSMISSION; EPIDEMIC; INFLUENZA; INFLUENZA VIRUS A H1N1; MASS SCREENING; STATISTICS; TIME; TRAVEL;

AIRCRAFT; DISEASE OUTBREAKS; DISEASE TRANSMISSION, INFECTIOUS; HUMANS; INCIDENCE; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA, HUMAN; MASS SCREENING; OSELTAMIVIR; TIME FACTORS; TRAVEL; VIETNAM;

EID: 77953248210     PISSN: 15491277     EISSN: 15491676     Source Type: Journal    
DOI: 10.1371/journal.pmed.1000277     Document Type: Article

References (40)

1. (2009) Influenza pandemic (H1N1) 2009: Viet Nam, patient data - 20090708.2450. ProMED-mail.
2. (2009) Influenza pandemic (H1N1) 2009: Viet Nam, patient data update - 20090809.2819. ProMED-mail.
3. (2009) Influenza pandemic (H1N1) 2009: Viet Nam, virus clearance - 20091011.3519. ProMED-mail.
4. (2009) Daily health reports. Ho Chi Minh City Health Services.
5. WHO/USCDC (2009) CDC Protocol for realtime RTPCR for influenza A(H1N1) - revision 1 30 April 2009.
6. Guan Y, Peiris JS, Lipatov AS, Ellis TM, Dyrting KC, et al. (2002) Emergence of multiple genotypes of H5N1 avian influenza viruses in Hong Kong SAR. Proc Natl Acad Sci U S A 99: 8950-8955.
7. Potier M, Mameli L, Belisle M, Dallaire L, Melancon SB (1979) Fluorometric assay of neuraminidase with a sodium (4-methylumbelliferyl-alpha-D-N-acetylneuraminate) substrate. Anal Biochem 94: 287-296.
8. Wetherall NT, Trivedi T, Zeller J, Hodges-Savola C, McKimm-Breschkin JL, et al. (2003) Evaluation of neuraminidase enzyme assays using different substrates to measure susceptibility of influenza virus clinical isolates to neuraminidase inhibitors: report of the neuraminidase inhibitor susceptibility network. J Clin Microbiol 41: 742-750.
9. Matrosovich M, Matrosovich T, Carr J, Roberts NA, Klenk HD (2003) Overexpression of the alpha-2,6-sialyltransferase in MDCK cells increases influenza virus sensitivity to neuraminidase inhibitors. J Virol 77: 8418-8425.
10. Reich NG, Lessler J, Cummings DA, Brookmeyer R (2009) Estimating incubation period distributions with coarse data. Stat Med 28: 2769-2784.
11. Fraser C, Donnelly CA, Cauchemez S, Hanage WP, Van Kerkhove MD, et al. (2009) Pandemic potential of a strain of influenza A (H1N1): early findings. Science 324: 1557-1561.
12. Ferguson NM, Cummings DA, Cauchemez S, Fraser C, Riley S, et al. (2005) Strategies for containing an emerging influenza pandemic in Southeast Asia. Nature 437: 209-214.
13. Cowling BJ, Fang VJ, Riley S, Malik Peiris JS, Leung GM (2009) Estimation of the serial interval of influenza. Epidemiology 20: 344-347.
14. Wallinga J, Lipsitch M (2007) How generation intervals shape the relationship between growth rates and reproductive numbers. Proc Biol Sci 274: 599-604.
15. de Silva UC, Warachit J, Waicharoen S, Chittaganpitch M (2009) A preliminary analysis of the epidemiology of influenza A(H1N1)v virus infection in Thailand from early outbreak data, June-July 2009. Euro Surveill 14: 19292.
16. Nguyen HT, Dharan NJ, Le MT, Nguyen NB, Nguyen CT, et al. (2009) National influenza surveillance in Vietnam, 2006-2007. Vaccine 28: 398-402.
17. Simmerman JM, Uyeki TM (2008) The burden of influenza in East and South-East Asia: a review of the English language literature. Influenza Other Respi Viruses 2: 81-92.
18. Mills CE, Robins JM, Bergstrom CT, Lipsitch M (2006) Pandemic influenza: risk of multiple introductions and the need to prepare for them. PLoS Med 3: e135. doi:10.1371/journal.pmed.0030135.
19. Cooper BS, Pitman RJ, Edmunds WJ, Gay NJ (2006) Delaying the international spread of pandemic influenza. PLoS Med 3: e212. doi:10.1371/journal.pmed.0030212.
20. Scalia Tomba G, Wallinga J (2008) A simple explanation for the low impact of border control as a countermeasure to the spread of an infectious disease. Math Biosci 214: 70-72.
21. Reed C, Angulo FJ, Swerdlow DL, Lipsitch M, Meltzer MI, et al. (2009) Estimates of the prevalence of pandemic (H1N1) 2009, United States, April-July 2009. Emerg Infect Dis 15: 2004-2007.
22. Novel influenza A(H1N1) investigation team (2009) Description of the early stage of pandemic (H1N1) 2009 in Germany, 27 April-16 June 2009. Euro Surveill 14: 19295.
23. Hahne S, Donker T, Meijer A, Timen A, van Steenbergen J, et al. (2009) Epidemiology and control of influenza A(H1N1)v in the Netherlands: the first 115 cases. Euro Surveill 14: 19267.
24. Hayden FG, Treanor JJ, Fritz RS, Lobo M, Betts RF, et al. (1999) Use of the oral neuraminidase inhibitor oseltamivir in experimental human influenza: randomized controlled trials for prevention and treatment. JAMA 282: 1240-1246.
25. Cunha BA, Pherez FM, Schoch P (2009) Diagnostic importance of relative lymphopenia as a marker of swine influenza (H1N1) in adults. Clin Infect Dis 49: 1454-1456.
26. Cao B, Li XW, Mao Y, Wang J, Lu HZ, et al. (2009) Clinical features of the initial cases of 2009 pandemic influenza A (H1N1) virus infection in China. N Engl J Med 361: 2507-2517.
27. Whitley RJ, Hayden FG, Reisinger KS, Young N, Dutkowski R, et al. (2001) Oral oseltamivir treatment of influenza in children. Pediatr Infect Dis J 20: 127-133.
28. De Serres F, Rouleau I, Hamelin M, Quach C, Boulianne N, et al. (2009) Shedding of novel 2009 pandemic H1N1 (nH1N1) virus at one week post illness onset [Abstract K-1918a].
29. Eggertson L (2009) Pandemic (H1N1) 2009 lives in some people for at least eight days after symptoms develop. Can Med Assoc J 181: E203.
30. Lye D, Chow A, Tan A, Win N, Win M, et al. (2009) Oseltamivir therapy and viral shedding in pandemic (H1N1) 2009.
31. Bhattarai A, Sessions W, Palekar R, Berman L, Winter J, et al. (2009) Viral shedding patterns of the pandemic influenza A H1N1 virus during an outbreak associated with an elementary school in Pennsylvania, May-June 2009.
32. Witkop CT, Duffy MR, Macias EA, Gibbons TF, Escobar JD, et al. (2009) Novel influenza A (H1N1) outbreak at the U.S. Air Force Academy: epidemiology and viral shedding duration. Am J Prev Med 38: 121-126.
33. Panning M, Eickmann M, Landt O, Monazahian M, Olschlager S, et al. (2009) Detection of influenza A(H1N1)v virus by real-time RT-PCR. Euro Surveill 14: 19329.
34. Kiso M, Mitamura K, Sakai-Tagawa Y, Shiraishi K, Kawakami C, et al. (2004) Resistant influenza A viruses in children treated with oseltamivir: descriptive study. Lancet 364: 759-765.
35. Whitley RJ, Hayden FG, Reisinger KS, Young N, Dutkowski R, et al. (2001) Oral oseltamivir treatment of influenza in children. Pediatr Infect Dis J 20: 127.
36. Gubareva LV, Kaiser L, Matrosovich MN, Soo-Hoo Y, Hayden FG (2001) Selection of influenza virus mutants in experimentally infected volunteers treated with oseltamivir. J Infect Dis 183: 523-531.
37. Stephenson I, Democratis J, Lackenby A, McNally T, Smith J, et al. (2009) Neuraminidase inhibitor resistance after oseltamivir treatment of acute influenza A and B in children. Clin Infect Dis 48: 389-396.
38. Bansal S, Pourbohloul B, Hupert N, Grenfell B, Myers LA (2009) The shifting demographic landscape of influenza, version 2. PLoS Currents Influenza. Available: http://knol.google.com/k/the-shifting-demographic-landscape-of-influenza.
39. Boni MF, Gog JR, Andreasen V, Feldman MW (2006) Epidemic dynamics and antigenic evolution in a single season of influenza A. Proc Biol Sci 273: 1307-1316.
40. Boni MF, Manh BH, Thai PQ, Farrar J, Hien TT, et al. (2009) Modelling the progression of pandemic influenza A (H1N1) in Vietnam and the opportunities for reassortment with other influenza viruses. BMC Medicine 7: 43.